EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion

Abstract Enhancer of zeste homolog 2 (EZH2) is often increased in malignant tumors and is involved in metastasis. EZH2 silences gene expression by tri-methylating the lysine 27 residue of histone H3 (H3K27me3). However, the mechanism underlying EZH2 promotion of ovarian cancer metastasis remains elu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaoqing Yi, Jianfeng Guo, Jing Guo, Si Sun, Ping Yang, Junjie Wang, Yuan Li, Lisha Xie, Jing Cai, Zehua Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/73dc2287caf146d6a51c6c9b7f2edf27
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:73dc2287caf146d6a51c6c9b7f2edf27
record_format dspace
spelling oai:doaj.org-article:73dc2287caf146d6a51c6c9b7f2edf272021-12-02T12:31:50ZEZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion10.1038/s41598-017-03362-z2045-2322https://doaj.org/article/73dc2287caf146d6a51c6c9b7f2edf272017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03362-zhttps://doaj.org/toc/2045-2322Abstract Enhancer of zeste homolog 2 (EZH2) is often increased in malignant tumors and is involved in metastasis. EZH2 silences gene expression by tri-methylating the lysine 27 residue of histone H3 (H3K27me3). However, the mechanism underlying EZH2 promotion of ovarian cancer metastasis remains elusive. Here, we showed that EZH2 is up-regulated in ovarian cancer and is associated with tumor metastasis and poor survival by mRNA sequencing and microarray results from databases. Tissue microarray and immunohistochemistry results revealed that EZH2 was negatively correlated with the expression of tissue inhibitor of metalloproteinases 2 (TIMP2). EZH2 overexpression inhibited TIMP2 expression and promoted proteolytic activities of matrix metalloproteinases 2 and 9 and vice versa. EZH2 promoted ovarian cancer invasion and migration, which could be largely reversed by TIMP2 down-regulation in vitro and in vivo. Both H3K27me3 inhibition and demethylation could reduce methylation of the TIMP2 promoter and finally reactivate TIMP2 transcription. The presence of EZH2 and H3K27me3 at the TIMP2 promoter was confirmed by chromatin immunoprecipitation. H3K27me3 and DNA methyltransferases at the promoter were significantly increased by EZH2 overexpression. These results suggest that EZH2 inhibits TIMP2 expression via H3K27me3 and DNA methylation, which relieve the repression of MMP and facilitate ovarian cancer invasion and migration.Xiaoqing YiJianfeng GuoJing GuoSi SunPing YangJunjie WangYuan LiLisha XieJing CaiZehua WangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-16 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xiaoqing Yi
Jianfeng Guo
Jing Guo
Si Sun
Ping Yang
Junjie Wang
Yuan Li
Lisha Xie
Jing Cai
Zehua Wang
EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
description Abstract Enhancer of zeste homolog 2 (EZH2) is often increased in malignant tumors and is involved in metastasis. EZH2 silences gene expression by tri-methylating the lysine 27 residue of histone H3 (H3K27me3). However, the mechanism underlying EZH2 promotion of ovarian cancer metastasis remains elusive. Here, we showed that EZH2 is up-regulated in ovarian cancer and is associated with tumor metastasis and poor survival by mRNA sequencing and microarray results from databases. Tissue microarray and immunohistochemistry results revealed that EZH2 was negatively correlated with the expression of tissue inhibitor of metalloproteinases 2 (TIMP2). EZH2 overexpression inhibited TIMP2 expression and promoted proteolytic activities of matrix metalloproteinases 2 and 9 and vice versa. EZH2 promoted ovarian cancer invasion and migration, which could be largely reversed by TIMP2 down-regulation in vitro and in vivo. Both H3K27me3 inhibition and demethylation could reduce methylation of the TIMP2 promoter and finally reactivate TIMP2 transcription. The presence of EZH2 and H3K27me3 at the TIMP2 promoter was confirmed by chromatin immunoprecipitation. H3K27me3 and DNA methyltransferases at the promoter were significantly increased by EZH2 overexpression. These results suggest that EZH2 inhibits TIMP2 expression via H3K27me3 and DNA methylation, which relieve the repression of MMP and facilitate ovarian cancer invasion and migration.
format article
author Xiaoqing Yi
Jianfeng Guo
Jing Guo
Si Sun
Ping Yang
Junjie Wang
Yuan Li
Lisha Xie
Jing Cai
Zehua Wang
author_facet Xiaoqing Yi
Jianfeng Guo
Jing Guo
Si Sun
Ping Yang
Junjie Wang
Yuan Li
Lisha Xie
Jing Cai
Zehua Wang
author_sort Xiaoqing Yi
title EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
title_short EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
title_full EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
title_fullStr EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
title_full_unstemmed EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
title_sort ezh2-mediated epigenetic silencing of timp2 promotes ovarian cancer migration and invasion
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/73dc2287caf146d6a51c6c9b7f2edf27
work_keys_str_mv AT xiaoqingyi ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
AT jianfengguo ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
AT jingguo ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
AT sisun ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
AT pingyang ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
AT junjiewang ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
AT yuanli ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
AT lishaxie ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
AT jingcai ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
AT zehuawang ezh2mediatedepigeneticsilencingoftimp2promotesovariancancermigrationandinvasion
_version_ 1718394285670268928